ChartMill · Sep 22, 2026
What's going on in today's session
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
GE
NASDAQ · GELS
Gelteq Limited Ordinary Shares
Healthcare · Drug Manufacturers - Specialty & Generic
$0.55
Up+$0.01 (+1.94%)
Updated Oct 9, 2026, 2:01 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 9.92M
- P/E ratio
- 0
- Dividend yield
- 0.00%
- 52-week range
- $0.39 – $2.01
- Volume
- 18.62K
- Avg. volume
- 1.07M
Price performance · GELS
GELS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
GELS closed at $0.55 after 21 trading sessions, down 30.28% for the selected period.
- Last close
- $0.55
- Period change
- -30.28%
- Period low
- $0.52
- Period high
- $0.79
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $0.5485 | $0.5525 | $0.54 | $0.5488 | 18.62K |
| Oct 7, 2026 | $0.5705 | $0.58 | $0.5501 | $0.5601 | 89.39K |
| Oct 6, 2026 | $0.5241 | $0.5801 | $0.5241 | $0.5797 | 72.62K |
| Oct 5, 2026 | $0.538 | $0.571 | $0.52 | $0.5437 | 37.34K |
| Oct 2, 2026 | $0.5265 | $0.5422 | $0.52 | $0.5213 | 70.75K |
| Oct 1, 2026 | $0.5318 | $0.554 | $0.50 | $0.5428 | 202.89K |
| Sep 30, 2026 | $0.533 | $0.5593 | $0.52 | $0.53 | 43.92K |
| Sep 29, 2026 | $0.54 | $0.5464 | $0.5221 | $0.5311 | 55.6K |
| Sep 28, 2026 | $0.5517 | $0.5599 | $0.5265 | $0.5469 | 96.33K |
| Sep 25, 2026 | $0.5457 | $0.5469 | $0.525 | $0.546 | 79.86K |
| Sep 24, 2026 | $0.5201 | $0.585 | $0.52 | $0.55 | 285.68K |
| Sep 23, 2026 | $0.542 | $0.6365 | $0.526 | $0.6009 | 531.82K |
| Sep 22, 2026 | $0.5585 | $0.9461 | $0.4364 | $0.61 | 33.66M |
| Sep 21, 2026 | $0.558 | $0.6015 | $0.558 | $0.5711 | 31.65K |
| Sep 18, 2026 | $0.5797 | $0.5853 | $0.555 | $0.5619 | 76.57K |
| Sep 17, 2026 | $0.609 | $0.609 | $0.566 | $0.5797 | 63.42K |
| Sep 16, 2026 | $0.60 | $0.6324 | $0.5802 | $0.5802 | 85.34K |
| Sep 15, 2026 | $0.6675 | $0.6675 | $0.58 | $0.6156 | 103.75K |
| Sep 14, 2026 | $0.697 | $0.7099 | $0.65 | $0.6799 | 76.77K |
| Sep 11, 2026 | $0.7801 | $0.7801 | $0.70 | $0.7001 | 93.43K |
| Sep 10, 2026 | $0.784 | $0.87 | $0.64 | $0.7871 | 344.72K |
Latest GELS news
The latest Smart Investors Daily articles mentioning GELS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
GELS research
Overview
Company profile and research snapshot.
Company profile
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Benzinga · Sep 4, 2026
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million. Akanda (NASDAQ:AKAN) shares increased by 27.52% to $4.68.
Benzinga · Sep 3, 2026
Nasdaq Gains Over 200 Points; US Weekly Jobless Claims Edge Higher
U.S. stocks climbed, led by Nasdaq; communications shares rose, energy fell, while MIMI surged and RARE plunged after trial failures.
Benzinga · Jun 17, 2026
Gelteq Highlights Clinical And Commercial Progress, Advances Human And Veterinary Drug Programs Ahead Of Key FDA Milestones
Gelteq Limited (NASDAQ:GELS) ("Gelteq" or the "Company"), a biotechnology company developing a proprietary gel-based delivery platform for pharmaceutical, animal health and consumer health applications, today provided a
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
